Filing Details
- Accession Number:
- 0001883850-22-000077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-05 16:10:31
- Reporting Period:
- 2022-10-03
- Accepted Time:
- 2022-10-05 16:10:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-10-03 | 3,346 | $724.00 | 18,269 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,779 | Indirect | 2021 GRAT |
Common Stock | 5,000 | Indirect | 2022 GRAT |
Common Stock | 1,480 | Indirect | By 401(k) Plan |
Common Stock | 1,897 | Indirect | By Trust |
Common Stock | 1,348 | Indirect | by 2018 GRAT |
Common Stock | 25 | Indirect | by Trust for Daugh |
Common Stock | 25 | Indirect | by Trust for Son |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.